✦ LIBER ✦

Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy

✍ Scribed by Morihiko Ishizaki; Tetsuro Sasada; Akane Kunitomi; Yoshiteru Konaka; Masato Yagita; Shutaro Gunji; Michiyuki Kanai; Norihiro Nishimoto; Arimichi Takabayashi

Publisher: Springer
Year: 2007
Tongue: English
Weight: 89 KB
Volume: 393
Category: Article
ISSN: 1435-2451
DOI: 10.1007/s00423-007-0217-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of a patient with t

Successful treatment of a patient with takayasu arteritis using a humanized anti–interleukin-6 receptor antibody

✍ Norihiro Nishimoto; Hideko Nakahara; Naoko Yoshio-Hoshino; Toru Mima 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

Role of interleukin-6 in a patient with

Role of interleukin-6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin-6 receptor monoclonal antibody tocilizumab

✍ Prashantha M. Vaitla; Paul M. Radford; Patrick J. Tighe; Richard J. Powell; Eliz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Anti–interleukin-6 receptor antibody the

Anti–interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study

✍ Rainer H. Straub; Peter Härle; Seizo Yamana; Takemasa Matsuda; Kiyoshi Takasugi; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

Tocilizumab, a humanized anti-interleuki

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis

✍ Yoshihito Shima; Tetsuya Tomita; Taeko Ishii; Atsuyoshi Morishima; Yuichi Maeda; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 210 KB

Improvement of reduced serum cartilage o

Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab

✍ Shoko Nakajima; Takuya Naruto; Takako Miyamae; Tomoyuki Imagawa; Masaaki Mori; S 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 213 KB

Therapeutic benefit of blocking interleu

Therapeutic benefit of blocking interleukin-6 activity with an anti–interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double-blind, placebo-controlled, dose-escalation trial

✍ E. H. S. Choy; D. A. Isenberg; T. Garrood; S. Farrow; Y. Ioannou; H. Bird; N. Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views